October 27, 2025
The path from promising science to therapeutic impact in the clinic and market value is paved with more than groundbreaking research – it requires strategic communication that builds credibility, generates momentum, and attracts the capital essential for growth. But how does one demonstrate the tangible value of communication efforts? How does one prove that investor outreach, scientific communications, and stakeholder engagement are driving real business outcomes when the metrics feel intangible and the attribution is unclear? The struggle to quantify communication impact is neither new nor unique to biotech, but the industry's complexity amplifies this challenge.
Let’s explore how defining and embracing such measurements, not as a mere reporting exercise, but as a strategic tool can support the evolution and scaling of small and medium organizations.
The indirect nature of communication impact
Communication rarely drives immediate, linear outcomes. When a biotech company secures Series A funding six months after implementing a strategic investor relations plan, was it the communication strategy, the scientific milestones, the team's credibility, or market timing that sealed the deal? In reality, the impact and value added is a compounded effect of all of the above. A frequently overlooked example is the effect of internal communications impact on employee engagement, productivity, and retention, which manifests indirectly in deliverables across all functions, making the direct financial translation exceptionally difficult.
Frameworks which emphasize outcome-based measurements can be integrated as a feedback mechanism for data-driven refinement of the strategic direction of the organization.
The time lag between action and result
Biotech organizations operate on extended timelines. The effects of scientific communication initiatives may take months to years to manifest as complex measurable results, such as interest from potential investors and partners or regulatory decisions.
Establishing milestone-based measurement frameworks aligned with the funding and development stages allows longitudinal tracking of stage-specific communication effectiveness, recognizing that some impacts will only become apparent retrospectively. For example, for pre-seed companies, relevant metrics include leading indicators such as waitlist signups, engagement with prototypes, and qualitative insights from feedback. As the organization progresses to early stage, growth rate, retention metrics, and revenue indicators become relevant metrics.
The disconnected goals and siloed data
Communications teams often work with goals that aren't clearly aligned with overall business objectives, and the relevant data is scatted across multiple platforms and functions. When communication KPIs don't directly connect to performance indicators that matter to leadership (e.g., revenue, talent retention, regulatory milestones), ROI becomes nearly impossible to demonstrate, and impact is stunted.
Implementation of an integrated approach for evidence generation ensures that communication strategies are designed from the outset to support business outcomes. Working cross-functionally to identify shared KPIs between the organization’s main pillars (e.g., scientific, business development, investor relations, people & culture, commercial) and centralizing stakeholder input enable the consolidation of communication data and tracking of engagement across all relevant touchpoints.
The attribution complexity
With multiple communication channels, tactics, and messages operating simultaneously, understanding which specific initiative contributed to ROI becomes extraordinarily difficult. Did Investor A commit because of the webinar, the one-on-one meeting, the scientific publication, or the industry conference presentation?
A customized attribution model recognizing that scientific credibility-building (publications, conference presentations) and relationship-building (meetings, advisory board participation) work synergistically to provide more accurate insights.
The lack of standardized metrics
Unlike finance or operations, communications lacks universal metrics for measuring effectiveness. Each organization's unique goals and objectives require tailored evaluation approaches, making benchmarking and rigorous analysis challenging.
Implementation of integrated evaluation frameworks that provide a structured yet flexible approach to measurements across industry-relevant metrics that drive impact allows customization while maintaining methodological rigor. Investor and scientific communications are such industry-relevant metrics for biotech.
The strategic competitive advantage
The impact of the communication strategy on driving organizational goals can be measured by tracking credibility indicators, including media coverage quantity (milestone and partnership announcements, media mentions, analyst coverage), media coverage quality (tier of publications, sentiment analysis), speaking invitation frequency from prestigious forums, advisory board composition changes, due diligence completion rates and funding round velocity. The ultimate goal is connecting communication efforts to tangible business value. Here's how to make this connection clear, and use emerging insights to revise and refine strategy:
For Investor Relations: Track qualified investor pipeline growth, conversion rates at each stage, time-to-close for funding rounds, and post-money valuation trajectory. Calculate ROI by comparing the cost of the IR program against the incremental capital raised and favorable terms secured.
For Scientific Communications: Measure key opinion leader engagement quality, partnership inquiry frequency and quality, impact of publications (e.g., citations), and conference speaking invitation growth. Link these to partnership deal values and licensing opportunities secured.
For Internal Communications: Track employee engagement, retention rates (especially for critical scientific talent), time-to-hire for key positions, and productivity metrics. Calculate savings from reduced turnover and faster hiring against communication program costs.
For Stakeholder Engagement: Monitor relationship health, stakeholder satisfaction, responsiveness to key initiatives, and advocacy behaviors. Connect these to reduced friction in business development, faster partnership negotiations, and expanded network access.
Successful organizations are those who strategically measure, optimize, and scale their communication efforts based on data-driven insights. This, however, requires a mindset shift to embracing data-driven communication strategies as a competitive advantage – the intelligence system that reports on what's working, what's not, and where to focus the limited resources for maximum impact. By implementing robust measurement frameworks adapted to biotech's unique challenges, early- and mid-stage companies can demonstrate their communication value, justify continued investment, and ultimately accelerate their path to market.